Edwards Lifesciences 관리
관리 기준 확인 3/4
Edwards Lifesciences CEO는 Bernard Zovighian, May2023 에 임명되었습니다 의 임기는 1.5 년입니다. 총 연간 보상은 $ 12.87M, 7.6% 로 구성됩니다. 7.6% 급여 및 92.4% 보너스(회사 주식 및 옵션 포함). 는 $ 4.84M 가치에 해당하는 회사 주식의 0.012% 직접 소유합니다. 4.84M. 경영진과 이사회의 평균 재임 기간은 각각 5.2 년과 4.5 년입니다.
주요 정보
Bernard Zovighian
최고 경영자
US$12.9m
총 보상
| CEO 급여 비율 | 7.6% |
| CEO 임기 | 1.5yrs |
| CEO 소유권 | 0.01% |
| 경영진 평균 재임 기간 | 5.2yrs |
| 이사회 평균 재임 기간 | 4.5yrs |
최근 관리 업데이트
Recent updates
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Nov 11
Edwards Lifesciences Q3: Divesting Critical Care And Focusing On Structural Hearts
Oct 25Bearish: Analysts Just Cut Their Edwards Lifesciences Corporation (NYSE:EW) Revenue and EPS estimates
Sep 11Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
Aug 30Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$2b |
| Jun 30 2024 | n/a | n/a | US$2b |
| Mar 31 2024 | n/a | n/a | US$1b |
| Dec 31 2023 | US$13m | US$973k | US$1b |
| Sep 30 2023 | n/a | n/a | US$1b |
| Jun 30 2023 | n/a | n/a | US$1b |
| Mar 31 2023 | n/a | n/a | US$1b |
| Dec 31 2022 | US$3m | US$642k | US$2b |
보상 대 시장: Bernard 의 총 보상 ($USD 12.87M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 12.74M ).
보상과 수익: Bernard 의 보상은 지난 1년 동안 20% 이상 증가했습니다.
CEO
Bernard Zovighian (56 yo)
1.5yrs
테뉴어
US$12,869,020
보상
Mr. Bernard J. Zovighian serves as Chief Executive Officer and Director at Edwards Lifesciences Corp since May 11, 2023 and was its President at Edwards Lifesciences Corp since January 1, 2023 until May 11...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$12.87m | 0.012% $ 4.8m | |
| Corporate VP & CFO | 10.8yrs | US$5.95m | 0.046% $ 18.5m | |
| Corporate Vice President of Strategy & Corporate Development | 8.8yrs | US$4.29m | 0.035% $ 14.0m | |
| Corporate VP and Group President of TAVR & Surgical Structural Heart | 1.8yrs | US$5.40m | 0.030% $ 12.1m | |
| Principal Accounting Officer | less than a year | 데이터 없음 | 0.00030% $ 119.9k | |
| Corporate VP of Advanced Technology & Chief Scientific Officer | 5.8yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Corporate VP & General Counsel | 5.2yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Vice President of Public Affairs | 11.4yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Vice President of Human Resources | 12.3yrs | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Quality & Regulatory Compliance | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| GM & Senior VP of Surgical Structural Heart | 1.3yrs | 데이터 없음 | 0.00021% $ 83.9k |
5.2yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 관리: EW 의 관리팀은 노련하고 경험 (평균 재직 기간 5.2 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Director | 1.5yrs | US$12.87m | 0.012% $ 4.8m | |
| Independent Director | 9.8yrs | US$335.06k | 0.012% $ 4.9m | |
| Independent Director | 4.3yrs | US$329.97k | 0.0013% $ 523.5k | |
| Independent Director | 8.7yrs | US$335.06k | 0.012% $ 4.8m | |
| Independent Director | 8.3yrs | US$356.42k | 0.0046% $ 1.8m | |
| Independent Chairman | 10yrs | US$347.97k | 0.012% $ 4.7m | |
| Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Independent Director | 4.5yrs | US$334.97k | 0.0019% $ 747.3k |
4.5yrs
평균 재임 기간
64yo
평균 연령
경험이 풍부한 이사회: EW 의 이사회는 경험(평균 재직 기간 4.5 년)으로 간주됩니다.